Report
⭐ 4.8
Impact Investing for Pharmaceutical Firms: Resilience And Continuity | A difference-in-differences analysis
Abstract
This report investigates “Impact Investing for Pharmaceutical Firms: Resilience And Continuity | A difference-in-differences analysis” using a panel regression with fixed effects. Through a behavioral lens, the analysis integrates multi-source data to derive novel empirical evidence for researchers and practitioners.